Polar Capital Adjusts Stake in Renalytix PLC
TipRanksMay 1 12:29 ET
CVI Investments Increases Stake in Renalytix AI
TipRanksApr 30 02:57 ET
Renalytix AI Plc Expands Share Offerings
TipRanksApr 29 02:45 ET
Renalytix AI Sees Major Stake Acquisition
TipRanksApr 26 11:47 ET
Renalytix AI Expands Share Capital With New Issuance
TipRanksApr 25 09:48 ET
Renalytix AI Announces Fundraising, Executive Changes, and Shareholder Approval
TipRanksApr 23 17:13 ET
Renalytix AI Expands Capital With New Share Sale
TipRanksApr 22 13:00 ET
Renalytix: All Resolutions Were Passed at General Meeting
Renalytix: All Resolutions Were Passed at General Meeting
Dow JonesApr 22 11:10 ET
Renalytix Names Chief Business Officer as President
Renalytix (RENX.L) on Thursday said it appointed Chief Business Officer Howard Doran as president, with effect from April 30. Doran will succeed Thomas McLain, the in-vitro diagnostics company noted.
MT NewswiresApr 18 03:54 ET
Renalytix Announces Leadership Shuffle
TipRanksApr 18 03:02 ET
Renalytix Files to Sell 19.99M Ordinary Shares for Holders
Seeking AlphaApr 17 17:04 ET
Renalytix AI Announces Convertible Bond Repayments and Share Issuance
TipRanksApr 10 16:12 ET
Renalytix Issues New Shares for Convertible Bonds Repayment
Renalytix (RENX.L) issued 1,818,081 American depositary shares to repay $1.1 million in principal and interest amount on its convertible bonds from Jan. 8 to April 7. The in-vitro diagnostics and labo
MT NewswiresApr 10 06:19 ET
Renalytix AI Announces Non-Filed $4 Million Financing Plan
TipRanksApr 8 07:52 ET
Press Release: Renalytix Announces Financing With Expected Size of up to $4 Million
Renalytix Announces Financing with Expected Size of up to $4 Million LONDON and SALT LAKE CITY, April 08, 2024 (GLOBE NEWSWIRE) -- Renalytix plc (NASDAQ: RNLX) (LSE: RENX) announces a registered dire
Dow JonesApr 8 07:00 ET
Renalytix Sells Stock to Raise Up to $4 Mln
By Elena Vardon Renalytix is selling some of its shares to raise up to $4 million in financing to support commercial sales activity as it moves forward in its formal sale process. The artificial int
WSJApr 8 03:08 ET
Express News | Renalytix PLC 13G Filing Shows CVI Investments, Inc. Reported A 6.9% Stake In the Co As Of March 28, 2024
Moomoo 24/7Apr 4 10:21 ET
Express News | Renalytix Announces That KidneyIntelX In-vitro Diagnostic Test Has Been Included In Final KDIGO (Kidney Disease Improving Global Outcomes) 2024 Clinical Practice Guideline For The Evaluation And Management Of Chronic Kidney Disease
Moomoo 24/7Mar 14 07:18 ET
KidneyIntelX Included in Final KDIGO 2024 Clinical Guideline for Chronic Kidney Disease (CKD)
LONDON and SALT LAKE CITY, March 14, 2024 (GLOBE NEWSWIRE) -- Renalytix plc (NASDAQ:RNLX) (LSE: RENX) (Renalytix) announces that the KidneyIntelX In-Vitro Diagnostic test has been included in the final KDIGO (Kidney
GlobeNewswireMar 14 07:00 ET
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
GainersNuCana (NASDAQ:NCNA) shares moved upwards by 110.6% to $0.81 during Wednesday's pre-market session. The market value of their outstanding shares is at $42.7 million. Kintara Therapeutics (NASDA
BenzingaMar 13 09:06 ET
No Data
No Data